-+ 0.00%
-+ 0.00%
-+ 0.00%

Aethlon Medical Q2 EPS $(2.60) Misses $(2.25) Estimate

Benzinga·11/12/2026 21:34:26
Listen to the news
Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(2.60) per share which missed the analyst consensus estimate of $(2.25) by 15.56 percent. This is a 86.1 percent increase over losses of $(18.70) per share from the same period last year.